KR890007741A - 진통제 - Google Patents

진통제 Download PDF

Info

Publication number
KR890007741A
KR890007741A KR1019880014833A KR880014833A KR890007741A KR 890007741 A KR890007741 A KR 890007741A KR 1019880014833 A KR1019880014833 A KR 1019880014833A KR 880014833 A KR880014833 A KR 880014833A KR 890007741 A KR890007741 A KR 890007741A
Authority
KR
South Korea
Prior art keywords
alkoxy
alkyl
formula
physiologically acceptable
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019880014833A
Other languages
English (en)
Korean (ko)
Inventor
라다쯔 페터
베버 볼프-디이트리히
바버 앤드류
볼프 한스-페터
제이프리트 크리스토프
Original Assignee
나우만, 호이만
메르크 파텐트 게젤샤프트 미트 배슈랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나우만, 호이만, 메르크 파텐트 게젤샤프트 미트 배슈랭크터 하프퉁 filed Critical 나우만, 호이만
Publication of KR890007741A publication Critical patent/KR890007741A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1019880014833A 1987-11-16 1988-11-11 진통제 Ceased KR890007741A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3738844.4 1987-11-16
DE19873738844 DE3738844A1 (de) 1987-11-16 1987-11-16 Analgetikum

Publications (1)

Publication Number Publication Date
KR890007741A true KR890007741A (ko) 1989-07-05

Family

ID=6340578

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880014833A Ceased KR890007741A (ko) 1987-11-16 1988-11-11 진통제

Country Status (15)

Country Link
US (1) US4950648A (https=)
EP (1) EP0316668B1 (https=)
JP (1) JPH01160919A (https=)
KR (1) KR890007741A (https=)
AT (1) ATE89481T1 (https=)
AU (1) AU616695B2 (https=)
CA (1) CA1317549C (https=)
DE (2) DE3738844A1 (https=)
ES (1) ES2069541T3 (https=)
GR (1) GR3007918T3 (https=)
HU (1) HU203199B (https=)
IE (1) IE61301B1 (https=)
PH (1) PH25353A (https=)
PT (1) PT89000B (https=)
ZA (1) ZA888574B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
US5095019A (en) * 1990-08-27 1992-03-10 Hoechst-Roussel Pharmaceuticals Inc. 4-substituted dihydropyrido(4,3-D)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
US6166019A (en) * 1998-07-16 2000-12-26 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
WO2001089508A1 (en) * 2000-05-24 2001-11-29 University Of Kentucky Research Foundation Novel long acting, reversible veterinary sedative and analgesic and method of use
FR2832711B1 (fr) 2001-11-26 2004-01-30 Warner Lambert Co Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
EP1680115A1 (en) * 2003-10-30 2006-07-19 Tioga Pharmaceuticals, Inc. Use of selective opiate receptor modulators in the treatment of neuropathy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB843073A (en) * 1958-05-09 1960-08-04 Toraude Lab 2-methyl-3-orthotolyl-4-quinazolone and acid addition salts thereof
FR1043M (fr) * 1960-12-28 1962-02-09 Soc Ind Fab Antibiotiques Sifa Dérivé de la quinazolone et ses sels, utilisés en thérapeutique.
US3919425A (en) * 1971-04-09 1975-11-11 Miles Lab Method of producing vasodilation using certain 3-substituted-quinazoline derivatives
DE2143117A1 (de) * 1971-08-28 1973-03-08 Troponwerke Dinklage & Co Neue 2-methyl-3-geschweifte klammer auf 3- eckige klammer auf 4-phenylpiperazinyl(1) eckige klammer zu -2-hydroxypropyl geschweifte klammer zu chinazolinon-(4)derivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
DE3012837A1 (de) * 1979-04-10 1980-10-30 Sandoz Ag Analgetische und myotonolytische praeparate
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
DE3601731A1 (de) * 1986-01-22 1987-07-23 Merck Patent Gmbh Pyrimidinderivate

Also Published As

Publication number Publication date
ZA888574B (en) 1989-08-30
ATE89481T1 (de) 1993-06-15
AU616695B2 (en) 1991-11-07
AU2510788A (en) 1989-05-18
EP0316668B1 (de) 1993-05-19
IE883417L (en) 1989-05-16
PH25353A (en) 1991-05-13
GR3007918T3 (https=) 1993-08-31
DE3738844A1 (de) 1989-05-24
US4950648A (en) 1990-08-21
IE61301B1 (en) 1994-10-19
HUT48818A (en) 1989-07-28
EP0316668A2 (de) 1989-05-24
PT89000A (pt) 1988-12-01
HU203199B (en) 1991-06-28
CA1317549C (en) 1993-05-11
EP0316668A3 (en) 1990-09-19
ES2069541T3 (es) 1995-05-16
PT89000B (pt) 1993-02-26
JPH01160919A (ja) 1989-06-23
DE3881164D1 (de) 1993-06-24

Similar Documents

Publication Publication Date Title
KR960704884A (ko) 항종양제 또는 항바이러스제로서의 디스타마이신 A 동족체 (Distamycin A analogues as antitumour or antiviral agents)
KR890000470A (ko) 2,2-디메틸크로만-3-올 유도체, 그의 제조방법 및 그를 함유하는 약학 조성물
KR920014805A (ko) 퀴나졸리논 화합물, 그의 제약학적 조성물 및 그의 제조방법
KR920021556A (ko) 라파 마이신 이량체
KR900006296A (ko) 이미다졸린 유도체 및 그의 제조방법
KR960007592A (ko) 신규한 피롤로카바졸
KR880000413A (ko) 항알레르기 및 소염 제제와 그의 제조방법
KR890007741A (ko) 진통제
KR890014542A (ko) 4-치환된 피라졸로[3,4-d] 피리미딘 유도체
KR880012586A (ko) 새로운 피리딜 및 피리미딜 유도체
KR910009259A (ko) 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체
KR900018113A (ko) 티에노-트리아졸로-디아제핀 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR890006625A (ko) 2,2-디메틸크로멘 유도체, 그의 제조방법 및 그것을 함유하는 약학 조성물
KR920004394A (ko) 티에노디아제핀 이의 제조방법 및 paf-길항 활성을 지닌 약제학적 조성물로서의 이의 용도
KR900012903A (ko) 피롤리딘 화합물 및 약제학적 용도
KR910004557A (ko) 2,4,6-치환 페놀 유도체
KR900014397A (ko) 티에노-트리아졸로-디아제핀 술포닐 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR880007494A (ko) 5-아릴-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그들의 용도
KR900012925A (ko) 인돌 유도체
KR880008995A (ko) 2-알킬설피닐-4(3h)-퀴나졸리논 유도체, 이의 제조방법 및 약학적 조성물
KR890009890A (ko) 하이드록시 피리미딘의 아실 유도체
KR850000415A (ko) 퀴나졸리논 유도체의 제조방법
KR890700584A (ko) 헤테로아릴카르복시아미드 유도체 그의 제조방법 및 그것을 함유하는 의약조성물
KR840005105A (ko) 의약용 피리다지논류 유도체의 제조방법
KR880001630A (ko) 5-플루오로우라실 유도체 및 그의 용도

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19881111

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19931101

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19881111

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19970423

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19970716

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19970423

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I